The effect of ultrasound-guided botulinum toxin injections on pain, functionality, spasticity, and range of motion in patients with post-stroke upper extremity spasticity

被引:0
作者
Celebi, G. [1 ]
Ayyildiz, A. [2 ]
Inceoglu, S. Ciftci [3 ]
Kuran, B. [3 ]
机构
[1] Bahcesehir Univ, Goztepe Med Pk Hosp, Dept Phys Med & Rehabil, Istanbul, Turkiye
[2] Cam & Sakura City Hosp, Dept Phys Med & Rehabil, Minist Hlth, Istanbul, Turkiye
[3] Univ Hlth Sci, Sisli Hamidiye Etfal Training & Res Hosp, Dept Phys Med & Rehabil, Istanbul, Turkiye
来源
REHABILITACION | 2025年 / 59卷 / 01期
关键词
Botulinum toxin; Spasticity; Stroke; Ultrasound-guided injection; UPPER-LIMB SPASTICITY; SHOULDER PAIN; DOUBLE-BLIND; STROKE; EPIDEMIOLOGY; HEMIPLEGIA; IMPROVE; ARM;
D O I
10.1016/j.rh.2024.100876
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: Spasticity developing in the upper extremity in stroke patients causes disability by limiting movement and causing pain. This study investigates the effects of botulinum toxin injections on pain, functionality, spasticity, and range of motion in hemiplegic patients with post-stroke spasticity. Materials and methods: The study involved a double-blind, prospective, randomized controlled trial with thirty-one stroke patients aged 35-80 who developed upper extremity spasticity. The study group (n = 16) received botulinum toxin-A (BT-A) injections in addition to conventional rehabilitation and stretching exercises, while the control group (n = 15) received placebo injections. Evaluations were conducted before treatment, in the second week, and three months after treatment. The study evaluated pain relief through the Visual Analog Scale (VAS), assessed spasticity with the Modified Ashworth Scale (MAS), and measured functionality using the Fugl Meyer Assessment Scale (FMAS) and the Box Block Test (BBT). Results: The mean age of patients was 56.03 +/- 11.81. The median time after stroke was 24 months. The BT-A group demonstrated significantly lower VAS and MAS scores compared to controls at both 2 weeks and 3 months after treatment. Additionally, the BT-A group showed significantly higher changes in arm, wrist, and total FMAS scores compared to the control group. However, no significant difference was found in terms of hand, coordination, and speed FMAS score changes. Conclusions: The results of our study demonstrated that BT-A injection with ultrasonography guidance is an effective method for alleviating pain caused by passive shoulder movement, significantly reducing spasticity, and markedly improving motor functions. (c) 2024 Sociedad Espanola de Rehabilitacio<acute accent>n y Medicina F & imath;<acute accent>sica. Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:10
相关论文
共 27 条
  • [21] Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions
    Saini, Vasu
    Guada, Luis
    Yavagal, Dileep R.
    [J]. NEUROLOGY, 2021, 97 (20S) : S6 - S16
  • [22] Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens
    Slawek, J
    Bogucki, A
    Reclawowicz, D
    [J]. NEUROLOGICAL SCIENCES, 2005, 26 (01) : 32 - 39
  • [23] Smith HS, 2009, PAIN PHYSICIAN, V12, P479
  • [24] Struyf Pieter, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20042797
  • [25] Best Practice Guidelines for the Management of Patients with Post-Stroke Spasticity: A Modified Scoping Review
    Suputtitada, Areerat
    Chatromyen, Supattana
    Chen, Carl P. C.
    Simpson, David M.
    [J]. TOXINS, 2024, 16 (02)
  • [26] Toward an epidemiology of poststroke spasticity
    Wissel, Joerg
    Manack, Aubrey
    Brainin, Michael
    [J]. NEUROLOGY, 2013, 80 : S13 - S19
  • [27] Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A
    Yelnik, Alain P.
    Colle, Florence M.
    Bonan, Isabelle V.
    Vicaut, Eric
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (08) : 845 - 848